WELCOME TO The PHARMACEUTICAL REPORT
Pharma Innovation 2019
October 25, 2019
I'm For Real
Enter your details once to access all our information and resources
NuPharm Laboratories, a pharmaceutical development and manufacturing company, provides a wide range of services and products.
whitePaper | January 1, 2020
Life sciences is facing a number of disruptors: novel cell and gene therapies that will revolutionize manufacturing, drug delivery and pricing models; a battle for the best and brightest talent; political and public pressure on the price of medication as well as the implications of the fourth industrial revolution. These factors combine to make investment decisions more challenging. With life sciences firms placing an increasing focus on the most efficient use of capital and shorter delivery times, project delivery providers are striving to come up with leaner and more innovative strategies and solutions to meet these needs. Integrated Project Delivery (IPD) is one such strategy.
whitePaper | February 5, 2022
Essential medicine access is one of the main objectives of healthcare systems in and pharmaceutical supply chains
ensure that the right amount of medicine, with acceptable quality, will reach the customers in need
whitePaper | August 8, 2021
If Pharma is to create a new marketing and sales model that is fit for 2020, it will have to begin by analysing its own value chain to identify opportunities for working more closely with healthcare payers and providers. It will, for example, have to collaborate much more closely with payers (be they governments, health insurers, employers or patients) to ensure that it develops medicines which have real social and economic value.
whitePaper | January 31, 2022
COVID-19 is an infectious disease caused by a newly discovered coronavirus, which was
first identified in December 2019.
whitePaper | April 1, 2021
Every year, the U.S. pharmaceutical industry develops
a variety of new drugs that provide valuable medical
benefits. Many of those drugs are expensive and contribute to rising health care costs for the private sector and
the federal government. Policymakers have considered
policies that would lower drug prices and reduce federal
drug expenditures. Such policies would probably reduce
the industry’s incentive to develop new drugs.
If you recognize some of these challenges, download the Deck 7 Webinar & Virtual Events overview to see how we make it easy for busy marketers to run highly successful webinars and virtual events....
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE